Nurse and social worker telecare team intervention improved quality of life in high-risk patients with COPD, heart failure, or interstitial lung disease.
This randomized clinical trial examined the content, processes, and cost of delivering the ADAPT intervention among 153 high-risk patients with chronic obstructive pulmonary disease, heart failure, or interstitial lung disease. The setting was multisite. The primary outcomes included quality of life, disease-specific health status, depression, and anxiety. Secondary outcomes included intervention session frequency and duration, team recommendations, and per-patient cost.
The mean length of intervention was 115.1 days with a standard deviation of 33.4 days. Participants averaged 10.0 sessions with a nurse (SD 3.3) and 9.5 sessions with a social worker (SD 3.4). Completion of required social work sessions occurred in 80.4% of cases. All required nurse sessions were completed. Team discussions averaged 3.7 times per participant (SD 1.8). Participants received an average of 7 recommendations per participant (SD 3.8). Referrals or consults occurred in 79.7% of cases. Medication additions occurred in 58.1% of cases, medication changes in 31.8%, and tests in 33.1%.
The mean cost per patient was $1139.68 with a standard deviation of $368.15. Safety data regarding adverse events, serious adverse events, discontinuations, and tolerability were not reported. The study limitations were not reported. Funding or conflicts of interest were not reported. The practice relevance indicates that the intervention produced clinically meaningful changes in multiple quality of life outcomes for a relatively low cost.